Durvalumab Intravenous and Insulin Glargine (U-100) Vials
Determining the interaction of Durvalumab Intravenous and Insulin Glargine (U-100) Vials and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: durvalumab
Brand name: Imfinzi
Synonyms: Durvalumab
Generic Name: insulin glargine
Brand name: Basaglar KwikPen, Lantus, Lantus Solostar Pen, Toujeo SoloStar, Lantus OptiClik Cartridge, Toujeo Max SoloStar, Lantus SoloStar
Synonyms: Insulin glargine, Insulin Glargine
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Durvalumab Intravenous-Insulin Glargine (U-300) Pens
- Durvalumab Intravenous-Insulin glargine and lixisenatide
- Durvalumab Intravenous-Insulin glargine and lixisenatide Subcutaneous
- Durvalumab Intravenous-Insulin glargine, recombinant Subcutaneous
- Durvalumab Intravenous-Insulin glulisine
- Durvalumab Intravenous-Insulin Glulisine (Cartridges and Pens)
- Insulin Glargine (U-100) Vials-Dutasteride
- Insulin Glargine (U-100) Vials-Dutasteride and tamsulosin
- Insulin Glargine (U-100) Vials-Dutasteride and Tamsulosin Capsules
- Insulin Glargine (U-100) Vials-Dutasteride Capsules
- Insulin Glargine (U-100) Vials-Dutoprol
- Insulin Glargine (U-100) Vials-Duvelisib